CHEK2 and breast neoplasm: Also, BRCA1 mutated breast tumors are frequently reported to be of the basal-like intrinsic subtype, opposed to breast tumors from CHEK2 mutation carriers, which are reported to be mostly steroid hormone receptor positive (progesterone receptor/progesterone receptor (ER/PR) positive) [11].